Octant
Biotechnology ResearchCalifornia, United States51-200 Employees
Octant is a biotechnology research company based in Emeryville, California, focused on developing small-molecule therapies for diseases driven by protein misfolding. It pursues a pipeline across rare diseases, oncology, and immunology, aiming to advance drug candidates by integrating biology and chemistry. The firm emphasizes an automated, scalable approach to drug discovery that aims to accelerate research by coordinating biological and chemical insights. In 2026, Octant announced a collaboration with the Foundation Fighting Blindness to expand a natural history study for inherited retinal diseases caused by mutations in the RHO gene. It operates in the biotechnology research sector and maintains a mid-sized team.